Chen Chu

19PUBLICATIONS
105CO-AUTHORS
Molecular targetsCancer cell biologyHaematological tumoursCancer geneticsMedical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Nov 02, 2026
Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma.

|Jun 29, 2026
Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis.

|Mar 09, 2026
Glucosamine induces apoptosis of cholangiocarcinoma cells by suppressing high-mannose type N-glycosylation and EGFR/STAT3 signaling.

Orawan Waenphimai, Cheerapinya Taebprakhon, Chatchai Phoomak

|Feb 27, 2026
CRISP3, a Potential Tumor Suppressor, Inhibits the Progression of High-Grade Serous Ovarian Carcinoma by Modulating the PI3K/AKT Pathway.

Mingjun Ma, Xiu Tian, Weiwei Cao

|Feb 13, 2026
Cyclin D1/D2-CDK4 Drives Cell Migration by Orchestrating Cytoskeletal Dynamics Through a TGFβ-FAK-Rac1 Axis.

Ruifang Guo, Yihang Wang, Aiwen Zhang

|Dec 03, 2025
Unveiling EMC6 as a novel pathogenic determinant in hepatocellular carcinoma: orchestration of lipid metabolism through regulation of lipid droplet-associated enzyme HSD17B13.

Yun Zhang, Chanyu Xiong, Zhilin Jiang

Pageof 4

Frequent Collaborators

5 joint publications

Wenyi Wei

5 joint publications

Piotr Sicinski

4 joint publications

Jing Liu

3 joint publications

Yu Zhou